According to the latest report by IMARC Group “Artificial Insemination Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027“, The global artificial insemination market reached a value of US$ 1.9 Billion in 2021. Looking forward, IMARC Group expects the market to reach US$ 3.0 Billion by 2027, exhibiting a CAGR of 8.6% during 2022-2027.
Artificial insemination refers to an assisted fertilization treatment wherein the sperm is artificially introduced into the cervix and uterus of a female. This procedure is employed through artificial insemination homologous (AIH), artificial insemination donor semen (AID), or intrauterine insemination (IUI). Artificial insemination is beneficial for infertility, old age, poor sperm quality, polycystic ovary syndrome (PCOS), and endometriosis. Other than this, artificial insemination is also adopted in animal breeding to conserve endangered species.
Request for a free sample copy of this report: https://www.imarcgroup.com/artificial-insemination-market/requestsample
Note: We are regularly tracking the direct effect of COVID-19 on the market, along with the indirect influence of associated industries. These observations will be integrated into the report.
Market Trends:
The growing rate of infertility, changing lifestyles, and increasing awareness regarding the availability of alternative reproductive treatments are majorly driving the global artificial insemination market. The legalization of same-sex marriage by governments of various nations is further contributing to the market growth. Moreover, there has been an increase in the adoption of artificial insemination in the breeding of livestock animals as it is considered more hygienic, thereby preventing the spread of zoonotic diseases. This is also supported by the escalating demand for animal-based proteins.
Breakup by Type:
Breakup by Source Type:
Breakup by End Use:
Market Breakup by Region: